RiverFront Investment Group LLC Has $4.42 Million Stake in Oracle Corporation $ORCL

Key Points

• RiverFront Investment Group LLC more than doubled its Oracle stake in the fourth quarter, increasing holdings by 101.6% to 22,679 shares worth about $4.42 million.
• Oracle continues to attract generally bullish analyst coverage, with a Moderate Buy consensus rating and a consensus price target of $261.46, despite some firms trimming their targets.
• The company is drawing attention for its AI and cloud growth story, with recent commentary highlighting backlog growth, cloud infrastructure economics, and Oracle’s expanding role in enterprise and government AI use cases.

RiverFront Investment Group LLC raised its stake in Oracle Corporation (NYSE:ORCL - Free Report) by 101.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,679 shares of the enterprise software provider's stock after purchasing an additional 11,428 shares during the quarter. RiverFront Investment Group LLC's holdings in Oracle were worth $4,420,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. FSA Wealth Management LLC purchased a new position in shares of Oracle during the third quarter valued at approximately $28,000. Mpwm Advisory Solutions LLC boosted its position in shares of Oracle by 76.9% during the third quarter. Mpwm Advisory Solutions LLC now owns 115 shares of the enterprise software provider's stock valued at $32,000 after buying an additional 50 shares during the last quarter. Turning Point Benefit Group Inc. purchased a new position in shares of Oracle during the third quarter valued at approximately $35,000. HFM Investment Advisors LLC boosted its position in shares of Oracle by 290.9% during the fourth quarter. HFM Investment Advisors LLC now owns 129 shares of the enterprise software provider's stock valued at $25,000 after buying an additional 96 shares during the last quarter. Finally, Collier Financial purchased a new position in shares of Oracle during the third quarter valued at approximately $38,000. Hedge funds and other institutional investors own 42.44% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft cut their target price on Oracle from $375.00 to $300.00 and set a "buy" rating on the stock in a research report on Monday, March 9th. Guggenheim reaffirmed a "buy" rating and set a $400.00 target price on shares of Oracle in a research report on Friday, March 13th. Mizuho reduced their target price on Oracle from $400.00 to $320.00 and set an "outperform" rating for the company in a report on Monday, March 16th. Jefferies Financial Group reduced their target price on Oracle from $400.00 to $320.00 and set a "buy" rating for the company in a report on Thursday, March 5th. Finally, Bank of America started coverage on Oracle in a report on Tuesday, March 24th. They issued a "buy" rating and a $200.00 target price for the company. Three research analysts have rated the stock with a Strong Buy rating, twenty-nine have given a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $261.46.

Key Oracle News

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: 24/7 Wall St. reiterated a bullish view on Oracle (ORCL), setting a 12-month price target of about $245 and pointing to strong backlog growth and accelerating cloud infrastructure economics as key upside drivers.
• Positive Sentiment: Wedbush said Oracle is building a durable position for the next phase of the AI cycle, suggesting the market may be underestimating its role in future AI demand.
• Positive Sentiment: Coverage focused on Oracle’s “AI heavyweight” status as investors increasingly view its legacy software base, cloud expansion, and AI infrastructure exposure as a major advantage. Oracle Went From Tech Dinosaur to AI Heavyweight
• Positive Sentiment: Oracle also drew attention for expanding its agentic AI push through U.S. defense partnerships, reinforcing the idea that its AI platform is gaining traction in high-value government and enterprise use cases. Oracle Expands Its Agentic AI Push Through U.S. Defense Partnerships
• Neutral Sentiment: Oracle added Cleveland Clinic CEO Tomislav Mihaljevic to its board, which may support its healthcare strategy but is unlikely to be an immediate stock-moving catalyst. Oracle adds Cleveland Clinic CEO to board of directors

Insider Buying and Selling

In related news, EVP Stuart Levey sold 15,000 shares of the company's stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average price of $176.19, for a total value of $2,642,850.00. Following the transaction, the executive vice president owned 3,429 shares in the company, valued at approximately $604,155.51. This represents a 81.39% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 40.90% of the company's stock.

Oracle Price Performance

Oracle stock opened at $193.13 on Monday. Oracle Corporation has a 12 month low of $134.57 and a 12 month high of $345.72. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 3.66. The business's 50 day simple moving average is $162.96 and its 200 day simple moving average is $182.23. The company has a market cap of $555.44 billion, a price-to-earnings ratio of 34.67, a PEG ratio of 1.84 and a beta of 1.55.

Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings data on Tuesday, March 10th. The enterprise software provider reported $1.79 EPS for the quarter, beating the consensus estimate of $1.71 by $0.08. Oracle had a return on equity of 62.70% and a net margin of 25.30%.The business had revenue of $17.19 billion for the quarter, compared to the consensus estimate of $16.91 billion. During the same quarter in the prior year, the business earned $1.47 earnings per share. Oracle's revenue for the quarter was up 21.7% on a year-over-year basis. Oracle has set its Q4 2026 guidance at 1.960-2.000 EPS. Sell-side analysts forecast that Oracle Corporation will post 6.08 EPS for the current year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 24th. Investors of record on Thursday, April 9th were paid a $0.50 dividend. The ex-dividend date was Thursday, April 9th. This represents a $2.00 annualized dividend and a yield of 1.0%. Oracle's dividend payout ratio is presently 35.91%.

Oracle Profile

Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.

Oracle's product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.